Flat epithelial atypia: Concepts and controversies of an intraductal lesion of the breast

Pathology

Volumn 37, Issue 2, 2005, Pages 105-111

  Ho, Bernard Chi Shern ^a   Puay, Hoon Tan ^a  

^a SINGAPORE GENERAL HOSPITAL   (Singapore)

Author keywords

Columnar cell lesions; Core biopsies; DIN; Flat epithelial atypia; Microcalcifications

Indexed keywords

BREAST BIOPSY; BREAST CALCIFICATION; BREAST DISEASE; BREAST LESION; CANCER GENETICS; CLINICAL FEATURE; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; FLAT EPITHELIAL ATYPIA; HUMAN; IMMUNOPHENOTYPING; INTRADUCTAL CARCINOMA; MOLECULAR GENETICS; REVIEW;

EID: 17844391558     PISSN: 00313025     EISSN: 14653931     Source Type: Journal    
DOI: 10.1080/00313020500058532     Document Type: Article

References (27)

1. Schnitt SJ, Vincent-Salomon A. Columnar cell lesions of the breast. Adv Anat Pathol 2003; 10: 113-24.
2. Fraser JL, Raza S, Chorny K, et al. Columnar alteration with prominent apical snouts and secretions: a spectrum of changes frequently present in breast biopsies performed for microcalcifications. Am J Surg Pathol 1998; 22: 1521-7.
3. Koerner FC, Oyama T, Maluf H. Morphological observations regarding the origins of atypical cystic lobules (low-grade clinging carcinoma of flat type). Virchows Arch 2001; 439: 523-30.
4. Oyama T, Maluf H, Koerner F. Atypical cystic lobules: an early stage in the formation of low-grade ductal carcinoma in situ. Virchows Arch 1999; 435: 413-21.
5. Goldstein NS, O'Malley BA. Cancerization of small ectatic ducts of the breast by ductal carcinoma in situ cells with apocrine snouts: a lesion associated with tubular carcinoma. Am J Clin Pathol 1997; 107: 561-6.
6. Tavassoli FA, Hoefler H, Rosai J, et al. Intraductal proliferative lesions. In: Tavassoli FA, Devilee P, editors. World Health Organisation Classification of Tumours. Pathology and Genetics of Tumours of the Breast and Female Genital Organs. Lyon: IARC Press, 2003.
7. Wellings SR, Jensen HM, Marcum RG. An atlas of subgross pathology of the human breast with special reference to possible precancerous lesions. J Natl Cancer Inst 1975; 55: 231-73.
8. Kusama R, Fujimori M, Matsuyama I, et al. Clinicopathological characteristics of atypical cystic duct (ACD) of the breast: assessment of ACD as a precancerous lesion. Pathol Int 2000; 50: 793-800.
9. Azzopardi JG. Problems in breast pathology. In: Bennington JL, editor. Major Problems in Pathology. Philadephia: WB Saunders, 1979.
10. Tavassoli FA. Ductal carcinoma in situ: introduction of the concept of ductal intraepithelial neoplasia. Mod Pathol 1998; 11: 140-54.
11. Rosen PP. Columnar cell hyperplasia is associated with lobular carcinoma in situ and tubular carcinoma. Am J Surg Pathol 1999; 23: 1561.
12. Brogi E, Oyama T, Koerner FC. Atypical cystic lobules in patients with lobular neoplasia. Int J Surg Pathol 2001; 9: 201-6.
13. Bratthauer GL, Tavassoli FA. Assessment of lesions coexisting with various grades of ductal intraepithelial neoplasia of the breast. Virchows Arch 2004; 444: 340-4.
14. Moinfar F, Man YG, Bratthauer GL, et al. Genetic abnormalities in mammary ductal intraepithelial neoplasia-flat type ('clinging ductal carcinoma in situ'): a simulator of normal mammary epithelium. Cancer 2000; 88: 2072-81.
15. Fu M, Wang C, Li Z, et al. Minireview: Cyclin D1: Normal and abnormal functions. Endocrinology 2004; 145: 5439-47.
16. Chytil A, Waltner-Law M, West R, et al. Construction of a cyclin D1-Cdk2 fusion protein to model the biological functions of cyclin D1/Cdk2 complexes. J Biol Chem 2004; 279: 47688-98.
17. Kenemans P, Verstraeten RA, Verheijen RH. Oncogenic pathways in hereditary and sporadic breast cancer. Maturitas 2004; 49: 34-43.
18. Chunder N, Mandal S, Roy A, Roychoudhury S, Panda CK. Analysis of different deleted regions in chromosome 11 and their interrelations in early- and late-onset breast tumors: association with cyclin D1 amplification and survival. Diagn Mol Pathol 2004; 13: 172-82.
19. Ferguson AT, Evron E, Umbricht CB, et al. High frequency of hypermethylation at the 14-3-3 sigma locus leads to gene silencing in breast cancer. Proc Natl Acad Sci USA 2000; 97: 6049-54.
20. Vercoutter-Edouart AS, Lemoine J, Le Bourhis X, et al. Proteomic analysis reveals that 14-3-3sigma is down-regulated in human breast cancer cells. Cancer Res 2001; 61: 76-80.
21. Simooka H, Oyama T, Sano T, et al. Immunohistochemical analysis of 14-3-3 sigma and related proteins in hyperplastic and neoplastic breast lesions, with particular reference to early carcinogenesis. Pathol Int 2004; 54: 595-602.
22. Eusebi V, Feudale E, Foschini MP, et al. Long-term follow-up of in situ carcinoma of the breast. Semin Diagn Pathol 1994; 11: 223-35.
23. Bijker N, Peterse JL, Duchateau L, et al. Risk factors for recurrence and metastasis after breast-conserving therapy for ductal carcinoma-in-situ: analysis of European Organization for Research and Treatment of Cancer Trial 10853. J Clin Oncol 2001; 19: 2263-71.
24. Schnitt SJ. The diagnosis and management of pre-invasive breast disease: flat epithelial atypia - classification, pathologic features and clinical significance. Breast Cancer Res 2003; 5: 263-8.
25. Oyama T, Sano T, Hikino T, et al. Microcalcifications of breast cancer and atypical cystic lobules associated with infiltration of foam cells expressing osteopontin. Virchows Arch 2002; 440: 267-73.
26. Jacobs TW, Connolly JL, Schnitt SJ. Nonmalignant lesions in breast core needle biopsies: to excise or not to excise? Am J Surg Pathol 2002; 26: 1095-110.
27. Rosai J. Rosai and Ackerman's Surgical Pathology. 9th ed. Philadelphia: Mosby, 2004; 1786-7.